GSK693

CAS No. 1372891-37-6

GSK693 ( GSK-693;GSK 693 )

Catalog No. M11537 CAS No. 1372891-37-6

GSK693 (GSK-693) is a potent, direct inhibitor of M. tuberculosis enoyl-ACP reductase (InhA) with IC50 of 7 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK693
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK693 (GSK-693) is a potent, direct inhibitor of M. tuberculosis enoyl-ACP reductase (InhA) with IC50 of 7 nM.
  • Description
    GSK693 (GSK-693) is a potent, direct inhibitor of M. tuberculosis enoyl-ACP reductase (InhA) with IC50 of 7 nM, shows equally potent activity against M. tuberculosis H37Rv both intra and extracellularly (MIC=0.2 uM); exhibits activities against multidrug (MDR) and extensively (XDR) drug-resistant clinical isolates as well as in TB murine models when orally dosed.
  • Synonyms
    GSK-693;GSK 693
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1372891-37-6
  • Formula Weight
    419.54
  • Molecular Formula
    C16H17N7OS3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (S)-1-(4-methylthiazol-2-yl)-1-(5-((1-((2-methylthiazol-4-yl)methyl)-1H-pyrazol-3-yl)amino)-1,3,4-thiadiazol-2-yl)ethanol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Martínez-Hoyos M, et al. EBioMedicine. 2016 Jun;8:291-301.
molnova catalog
related products
  • MsbA inhibitor 1

    MsbA inhibitor 1 is a novel small molecule lipopolysaccharide biogenesis inhibitor.

  • SR 1078

    SR1078 is an agonist of retinoic acid receptor-related orphan receptor (ROR)α/γ.

  • Fidaxomicin

    Fidaxomicin(OPT-80; PAR-101) is anew class of narrow spectrum macrocyclic antibiotic drug.